Vanguard Capital Management
CPIX icon

Vanguard Capital Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Vanguard Capital Management’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.46M Buy
379,478
+17,719
+5% +$84.9K ﹤0.01% 3349
2026
Q1 		$1.18M Buy
+361,759
New +$1.39M ﹤0.01% 3512

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management's CPIX Position: Q2 2026 in Review

Vanguard Capital Management increased its Cumberland Pharmaceuticals (CPIX) stake by 4.9% in Q2 2026, buying an estimated $84.9K and bringing the position to 379,478 shares worth $2.46M. The position accounts for ﹤0.01% of the portfolio, ranked #3349.

Vanguard Capital Management first reported a position in CPIX in Q1 2026 and has held it in 2 quarters since. 32 funds tracked by Wall St. Rank hold CPIX as of Q2 2026.

  • Vanguard Capital Management held 379,478 shares of Cumberland Pharmaceuticals worth $2.46M as of Q2 2026.
  • Vanguard Capital Management bought 17,719 Cumberland Pharmaceuticals shares in Q2 2026, an estimated $84.9K.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3349 holding.
  • Vanguard Capital Management first reported a position in Cumberland Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 32 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.